Sonde Health Announces Patents Covering Methods of Detecting Vocal Biomarkers in Physical or Psychological Conditions
Sonde Health Inc., an affiliate of PureTech Health developing a voice-based technology platform for monitoring and diagnosing mental and physical medical conditions, announced that the United States Patent and Trademark Office (USPTO) and Intellectual Property Australia (IP Australia) have issued U.S. Patent No. 9,936,914 and Australian Patent No. 2014374349. The U.S. patent, which provides coverage until 2032, is focused on extracting proprietary acoustic features from targeted segments of speech to measure vocal biomarkers for physical or psychological conditions. The patent issued by IP Australia broadly covers the use of vocal biomarker technology to detect physical or psychological conditions in the human body and provides coverage until 2034. These technologies may potentially be used to detect a range of conditions including major depressive disorder (MDD), Parkinson’s disease, Alzheimer’s disease and multiple sclerosis, among others. Both patents are exclusively licensed under an agreement with the Massachusetts Institute of Technology (MIT).
Sonde’s proprietary voice-based technology, being developed internally, has been tested in over 3,000 subjects for the detection of neurophysiological conditions, such as depressive disorders. Sonde’s platform is designed to enable voice-interactive devices, including smartphones, to detect and quantify a rapidly growing number of health-related features through subtle characteristic changes in the voice.
Sonde Health's developer portal enables organizations to embed vocal biomarker health detection and monitoring in its mobile apps.
Sonde Health's voice-enabled health screening tool combines six-second voice analysis, COVID-19 questionnaire, and body temperature reading in one app.
NICE inContact, a NICE business, announced the expansion of its artificial intelligence applications with the Omilia conversational technology stack on CXexchange, an extensive marketplace featuring ready-to-use applications designed to integrate with NICE inContact CXone, the world's #1 cloud customer experience platform.
The ALS Association announced the launch of "Project Revoice," an international initiative to help people with ALS [also known as Motor Neurone Disease] record their voices so they still use their "voice" after they lose their ability to speak.
RIO, a cloud-based SAAS platform that creates custom SMS/MMS solutions for businesses, announced the release of their Live Chat Solution.